NCT01619410View on ClinicalTrials.gov

Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections

NATerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Skin Diseases, BacterialAbscess
Interventions
BIOLOGICAL

Linezolid

Linezolid 600 mg every 12 hours for 7 days

BIOLOGICAL

Clindamycin

Clindamycin 300 mg po every 6 hours for 7 days

Trial Locations (2)

30303

Grady Memorial Hospital, Atlanta

60637

University of Chicago Medical Center, Chicago

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Chicago

OTHER

NCT01619410 - Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections | Biotech Hunter | Biotech Hunter